Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery

Bioorg Med Chem. 2008 May 15;16(10):5501-13. doi: 10.1016/j.bmc.2008.04.015. Epub 2008 Apr 11.

Abstract

A combination of a literature survey, structure-based virtual screening and synthesis of a small library was performed to identify hits to the potential antimycobacterial drug target, glutamine synthetase. The best inhibitor identified from the literature survey was (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid (4, IC(50) of 610+/-15microM). In the virtual screening 46,400 compounds were docked and subjected to a pharmacophore search. Of these compounds, 29 were purchased and tested in a biological assay, allowing three novel inhibitors containing an aromatic scaffold to be identified. Based on one of the hits from the virtual screening a small library of 15 analogues was synthesized producing four compounds that inhibited glutamine synthetase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / chemistry
  • Amino Acids / pharmacology*
  • Binding Sites / drug effects
  • Caproates / chemistry
  • Caproates / pharmacology*
  • Computer Simulation
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Glutamate-Ammonia Ligase / antagonists & inhibitors*
  • Hydroxylysine / analogs & derivatives
  • Models, Molecular
  • Molecular Conformation
  • Mycobacterium tuberculosis / enzymology*
  • Organophosphorus Compounds
  • Small Molecule Libraries
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • (3-(diethoxyphosphoryl)phenylamino)acetic acid
  • Amino Acids
  • Caproates
  • Organophosphorus Compounds
  • Small Molecule Libraries
  • Hydroxylysine
  • Glutamate-Ammonia Ligase